TORVANTA
Other · S&P 500 · data as of 2026-10-05

UFPT stock analysis: UFPT

UFPT (UFPT) is an S&P 500 company in Other. It grades strongest on momentum and weakest on value.

The model's view of UFPT · subscribers

Where UFPT ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with UFPT · updated 2026-10-05 · from prices and SEC filings

UFPT price performance

UFPT against the S&P 500, one year
+0%+25%+50%UFPT +54%S&P 500 +18%2025-09-292026-10-05
Year to date+38.4%S&P 500 +14.5% · ahead by 23.9 pts
1 year+57.4%S&P 500 +17.0% · ahead by 40.4 pts
3 years+85.1%S&P 500 +89.3% · behind by 4.2 pts
5 years+384.5%S&P 500 +91.3% · ahead by 293.2 pts

Total returns with dividends reinvested.

UFPT factor grades

Each grade compares UFPT with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

DValueP/E 33.1x (industry 20.1x)FCF yield 3.0% (industry 6.0%)
CGrowthRevenue growth +7% (industry +8%)EPS growth +8% (industry +10%)
B-ProfitabilityOperating margin 15.3% (industry 9.6%)ROIC 13.8% (industry 10.1%)
A-Momentum12-month change +57%From 52-wk high -8%

UFPT in plain numbers

UFPT key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$2.4B
Revenue growth (y/y)+7%
Free-cash-flow yield3.0%
Dividend yieldn/a
Next earnings (expected)2026-11-02
Valuation measures
Market value$2.4B
Enterprise value$2.5B
P/E (trailing)33.1x
Forward P/E (Torvanta estimate)31.3x
PEG (Torvanta estimate)5.35
Price / sales3.8x
Price / book5.1x
EV / revenue3.9x
EV / EBITDA25.8x
Financial highlights
Revenue, last 12 months$631.6M
Net income, last 12 months$72.3M
EPS, last 12 months (GAAP)$9.28
Gross margin28.5%
Operating margin15.3%
Net margin11.4%
Return on equity17.1%
Return on invested capital13.8%
Cash$9.0M
Total debt$117.3M
Debt / equity0.25x
Interest cover12.4x
Current ratio3.00x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

UFPT earnings trends

Revenue vs earnings
$0$43.5M$87.0M$130.5M$174.0MSep 2024 Revenue: $145.2MDec 2024 Revenue: $144.1MMar 2025 Revenue: $148.1MJun 2025 Revenue: $151.2MSep 2025 Revenue: $154.6MDec 2025 Revenue: $148.9MMar 2026 Revenue: $154.2MJun 2026 Revenue: $174.0MSep 2024 Net income: $16.4MDec 2024 Net income: $16.4MMar 2025 Net income: $17.2MJun 2025 Net income: $17.2MSep 2025 Net income: $16.4MDec 2025 Net income: $17.6MMar 2026 Net income: $17.5MJun 2026 Net income: $20.9MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: 11.3%Net margin: 11.4%Net margin: 11.6%Net margin: 11.4%Net margin: 10.6%Net margin: 11.8%Net margin: 11.3%Net margin: 12.0%0%6%12%■ Revenue ■ Net income ━ Net margin
Earnings per share$0.0$0.7$1.3$2.0$2.7Sep 2024 EPS (GAAP, diluted): $2.1Dec 2024 EPS (GAAP, diluted): $2.1Mar 2025 EPS (GAAP, diluted): $2.2Jun 2025 EPS (GAAP, diluted): $2.2Sep 2025 EPS (GAAP, diluted): $2.1Dec 2025 EPS (GAAP, diluted): $2.3Mar 2026 EPS (GAAP, diluted): $2.2Jun 2026 EPS (GAAP, diluted): $2.7Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted) Change from a year earlier: Sep 2025 0% · Dec 2025 +7% · Mar 2026 +1% · Jun 2026 +21%

From the company's 10-Q and 10-K filings with the SEC.

UFPT financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$206.3M$353.8M$400.1M$504.4M$602.8M
Net income$15.9M$41.8M$44.9M$59.0M$68.3M
EPS (GAAP)$2.09$5.47$5.85$7.60$8.78
Free cash flow$8.9M$4.0M$30.8M$56.9Mn/a

UFPT earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-03$2.68+21%+15%+28.2%
2026-05-04$2.24+1%+4%+9.0%
2026-02-24$2.25+7%+3%-2.2%
2025-11-03$2.110%+6%+16.8%
2025-08-05$2.21+26%+37%-5.9%
2025-05-07$2.21+35%+41%+5.5%

About UFPT

HeadquartersNewburyport, MA
Industry (SEC code)Surgical & Medical Instruments & Apparatus
Fiscal year endsDecember 31
Incorporated inDE
Listed onNasdaq

From the company's SEC registration record.

Companies similar to UFPT

CompanyMarket valueP/ERevenue growthOperating margin12-month change
UFPT UFPT$2.4B33.1x+7%15.3%+57%
VC VC$2.4B11.7x-1%n/a-25%compare
ICHR ICHR$2.4Bn/a+9%-2.4%+206%compare
PDFS PDFS$2.4B224.3x+23%8.2%+115%compare
AAP AAP$2.4B28.9x-1%2.7%-34%
COTY COTY$2.4Bn/a-1%-1.4%-32%
PRLB PRLB$2.4B78.9x+10%6.6%+99%

All Other stock ratings

Frequently asked questions

Is UFPT stock a buy?

Torvanta does not tell individuals what to buy. Its grades for UFPT are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

What is UFPT's P/E ratio?

UFPT trades at about 33.1 times its last 12 months of GAAP earnings reported to the SEC, and about 31.3 times Torvanta's own estimate of the next 12 months.

When does UFPT report earnings next?

Based on its filing history, Torvanta expects UFPT to report around 2026-11-02.

How has UFPT performed against the S&P 500?

Over the past year UFPT returned +57.4%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer